| __timestamp | Lantheus Holdings, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 5078000000 |
| Thursday, January 1, 2015 | 78634000 | 4717000000 |
| Friday, January 1, 2016 | 75374000 | 5096000000 |
| Sunday, January 1, 2017 | 92157000 | 4986000000 |
| Monday, January 1, 2018 | 93326000 | 4214000000 |
| Tuesday, January 1, 2019 | 103132000 | 3806000000 |
| Wednesday, January 1, 2020 | 110171000 | 3671000000 |
| Friday, January 1, 2021 | 218817000 | 3528000000 |
| Saturday, January 1, 2022 | 233827000 | 3445000000 |
| Sunday, January 1, 2023 | 267194000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry players: Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc., from 2014 to 2023.
Teva, a global leader, has seen its SG&A expenses decrease by approximately 31% over the decade, reflecting strategic cost-cutting measures. In contrast, Lantheus, a smaller yet dynamic player, experienced a staggering 270% increase in SG&A expenses, indicative of its aggressive expansion and investment in market presence.
For investors and industry analysts, these trends highlight the contrasting strategies of established giants versus emerging innovators. Teva's focus on efficiency contrasts with Lantheus's growth-driven expenditure, offering valuable insights into their respective market strategies.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights